Navigation Links
Jefferson scientists find aging gene also protects against prostate cancer development

Cancer scientists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have shown that a gene that is involved in regulating aging also blocks prostate cancer cell growth. The researchers, led by Kimmel Cancer Center director Richard Pestell, M.D., Ph.D., hope the newly found connection will aid in better understanding the development of prostate cancer and lead to new drugs against the disease.

SIRT1 is a member of a family of enzymes called sirtuins that have far-reaching influence in all organisms, including roles in metabolism, gene expression and aging.

“We know that sirtuins play a role in aging, and that the risk for prostate cancer increases with aging, but no one has ever linked the two until now,?says Dr. Pestell, who is also professor and chair of cancer biology at Jefferson Medical College.

“We’ve shown that by making a prostate cancer with cells overexpressing a mutation for the androgen receptor, which is resistant to current forms of therapy, we can almost completely block the growth of these cells with SIRT1,?he says. Dr. Pestell and his team report their findings in November in the journal Molecular and Cellular Biology.

According to Dr. Pestell, prostate cancer cells can express a mutation that makes patients resistant to current forms of treatment such as hormonal therapy. Such therapy focuses on inactivating the androgen receptor by giving agents that shut off testosterone production.

In one experiment, the scientists took a series of mutations in androgen receptors from prostate cancer patients who are resistant to hormonal therapy and showed that SIRT1 blocks receptor activity, halting cancer growth. “We systematically tested each androgen receptor mutation,?Dr. Pestell explains. “These mutant receptors are resistant to current therapies and are all blocked by expression of SIRT1,?adding that prostate specific antigen (PSA) levels were used to confirm this. Rising PSA levels ar
'"/>

Source:Thomas Jefferson University


Page: 1 2

Related biology news :

1. Jefferson Virologists Coax HIV Out of Hiding
2. Jefferson researchers find nanoparticle shows promise in reducing radiation side effects
3. Jefferson biologist coaxing human embryonic stem cells to make dopamine with simpler, faster method
4. Jefferson scientists identify gene defect leading to abnormal skin development and cancer
5. Jefferson researchers building a better rabies vaccine
6. Jefferson scientists identify gene mutation potentially involved in breast cancer initiation
7. Immune cell communication key to hunting viruses, Jefferson immunologists show
8. Jefferson researchers uncover new way nature turns genes on and off
9. Jefferson scientists find high glucose before surgery raises risk of dangerous complications
10. Jefferson researchers discovery may change thinking on how viruses invade the brain
11. Elderly spinal cord injuries increase five-fold in 30 years, Jefferson neurosurgeons find

Post Your Comments:
(Date:11/6/2009)...burn Hills, MI-based Law Enforcement Intelligent D...ystem and patent-pending Biometric Access Control ... and Human Services, National Institutes of Health...ill support the NIH,s entire police force that is ...search agency. The project is expected to be comp...
(Date:11/5/2009)... a training grant in the amount of $2,756,719 by t...ve Graduation Education and Research Training (IGE...warded to Kent State. The grant, which is funded u... 2009, runs through 2014. , The grant funds an I...esource sensing (EARS). The purpose of the program...
(Date:11/4/2009)...hood obesity in the United States is reaching epid...ertising on daytime and prime time television devo...s about the role television plays in obesity, a st... of Nutrition Education and Behavior examines how...ge contributor to the problem. , Researchers at ...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 1Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 2Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 3Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 5Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 6Researchers Spot Genes Linked to Testicular Cancer 47451 1Researchers Spot Genes Linked to Testicular Cancer 47451 2FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 1FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 2FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 3FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 4FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 5FDA Approves Lamictal 28R 29XR 28TM 29 3B An Extended Release Once Daily New Generation Treatment for Epilepsy 47447 6
...ark December 13, 2007 The Juvenile Diabetes Rese...nder of type 1 diabetes research, awarded Professo...nhagens Department of Medical Biochemistry and Gen... cell regeneration and expansion during pregnancy ...or the treatment of type 1 diabetes. , The projec...
...University of Pennsylvania researchers have uncove... HSV-1, uses cooperating proteins found on its out...t them. Further, the studys authors say, they hav...se protein interactions using biomolecular complem...dings of the National Academy of Sciences, provide...
...ectly connect silicon circuits with brains are und...re nearing commercial application in many areas, a...ologist Theodore W. Berger of the University of So...ee which compiled the "International Assessment of...aces," published in October by the World Technolog...
Other Biology News:JDRF awards University of Copenhagen professor with grant to conduct innovative diabetes research 2Penn researchers shine the light of venus to learn how the herpes virus invades cells 2Brain-computer link systems on the brink of breakthrough, study finds 2
(Date:11/6/2009)... Nov. 6 Intarcia Therapeutics, Inc...0 (DUROS® continuous delivery of exenatide) p... Ninth Annual Diabetes Technology Meeting in San F.../cgi-bin/prnh/20050301/SFTU126LOGO ) ,, Conti...650 Lowers Plasma Glucose, HbA1c and Reduces Weigh...
(Date:11/5/2009)...., Nov. 5 GenVec, Inc. (...lts for the third quarter ended September 30, 2009...4 per share) for the three months ended September ...0.08 per share) in the comparable quarter of 2008....Vec,s net loss was $14.1 million ($0.15 per share)...
(Date:11/5/2009)...5 Imagenetix, Inc. (OTC ...m Spencer, President and CEO of Imagenetix, will b... LD MICRO Conference on Thursday, December 3rd, at..., About LD MICRO ,, LD MICRO is a by-invitat...ndervalued companies in the micro-cap space. Since...
(Date:11/5/2009).... 5 Transgenomic, Inc. (...l results for the quarter ended September 30, 2009... the tables that follow. ,, Third Quarter 2009...0 or $0.01 per share for the third quarter of 2009...r share for the third quarter of 2008. ,, Net ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
.... (Pink,Sheets: BMGP) has been rated Speculative B...esearch Analyst, Lisa Springer, CFA., The full re...., Anyone interested in receiving alerts regardin...members@beaconequity.com with "BMGP" in,the subje...magnetics Diagnostics Corp.,(BMGP) is a biotechnol...
...he nanoworld, researchers at the National Institut...rsity of Maryland-College Park have discovered tha...in bulk form behave as ductile as gold at the nano...re nanomachines. , NIST scientists Pradeep Namboo...ted* the latest incongruity between the macro and ...
...Nasdaq: DCGN ) today announced its consolidated f...cember 31, 2007. A conference call to discuss the,...bcast live tomorrow,Thursday, March 13, at 8:00am ...e year ended December 31, 2007 was $95.5 million,c...asic and diluted net,loss per share was $1.57 for ...
Other Biology Technology:BioMagnetics Diagnostics Corp. Rated 'Speculative Buy,' Target Price $1.42 by Beacon Equity Research 2Nanomaterials show unexpected strength under stress 2deCODE Genetics Announces Full-year 2007 Financial Results 2deCODE Genetics Announces Full-year 2007 Financial Results 3deCODE Genetics Announces Full-year 2007 Financial Results 4deCODE Genetics Announces Full-year 2007 Financial Results 5deCODE Genetics Announces Full-year 2007 Financial Results 6deCODE Genetics Announces Full-year 2007 Financial Results 7deCODE Genetics Announces Full-year 2007 Financial Results 8deCODE Genetics Announces Full-year 2007 Financial Results 9
RNA oligos ready-to-use from Thermo Scientific
...m7G(5')ppp(5')G (Cap Analog) is used for the synth...ription reactions. Substitution of cap analog for ...ption reaction results in the incorporation of the...ripts. Capped mRNAs are generally translated more ...
iEMS Incubator/Shaker 2 module from Thermo Scientific
...Source: Pseudomonas atlantica Description: Beta-Ag...s from low-melting-temperature agarose. Beta-Agara...es. Tested User Friendly Properties: Heat Inactiva...mum pH: 6.5 Purity: Tested for contaminating endon...
Biology Products: